New breast cancer drug vepdegestrant shows promising results in increasing survival rates for patients with ESR1 mutations.

Income investing isn’t meant to create fabulous wealth in a month or even a year. After a quarter-century of successful ...

There have been important recent advances in the management of Crohn's disease, including new classes of biological or small molecule therapies, an appreciation that endoscopic mucosal healing results ...

Stocks were boosted in May by easing trade tensions, solid corporate earnings and signs the U.S. economy remains resilient ...

This was the stock's second consecutive day of gains.

Investors flocked to shares of NRG as the energy supplier boosted capacity. UnitedHealth stock slumped, and the company’s CEO ...